The relationship between metabolic syndrome and prostate volume in men over sixties who underwent prostate health check-up

Korean Journal of Urology

Volumn 49, Issue 9, 2008, Pages 813-817

  Koo, Kyo Chul ^c   Cho, Kang Su ^c   Kang, Eun Mitt ^c   Kwon, Sung Won ^a,b   Hong, Sung Joon ^c  

^a CHA University   (South Korea)

^b Prostate Health Council Inc   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Metabolic syndrome X; Obesity; Prostatic hyperplasia; Urination disorders

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FASTING BLOOD GLUCOSE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KOREA; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MICTURITION DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTVOID RESIDUAL URINE VOLUME; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RESIDUAL VOLUME; URINE FLOW RATE; WAIST CIRCUMFERENCE;

EID: 53849136951     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2008.49.9.813     Document Type: Article

References (26)

1. Rhew HY, Koo JH, Cho SS, Kang JS, Lee CK, Kim JC, et al. The prevalence of BPH in Busan city over age 40. Korean J Urol 2001;42:223-7
2. Chung TG, Chung J, Lee MS, Ahn H. Prevalence of benign prostatic hyperplasia in Jeong-Eup area: community-based study. Korean J Urol 1999;40:52-8
3. Lee HL, Seo JW, Kim WJ. The prevalence of benign prostatic hyperplasia: community-based study in Chungbuk province. Korean J Urol 1999;40:1500-5
4. Hammarsten J, Hogstedt B. Hyperinsulinaenaia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001;39: 151-8
5. Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998;1:157-62
6. Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007;51:199-203
7. Gupta A, Gupta S, Pavuk M, Roehrborn CG. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 2006;68:1198-205
8. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 2001;54:935-44
9. Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994;140:989-1002
10. Lee S, Min HG, Choi SH, Kim YJ, Oh SW, Kim YJ, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) 2006;14:172-9
11. Zhuang TN, Ly LP, Cumming RG, Handelsman DJ. Growth and development during early manhood as determinants of prostate size in later life. J Clin Endocrinol Metab 2005; 90:6055-63
12. Kim JH, Shim BS, Hong YS. The relating factors of metabolic syndrome to benign prostatic hyperplasia. Korean J Urol 2005; 46:1046-50
13. Kim JH, Shim BS, Kim JS, Hon YS. Voiding dysfunction of men is associated with metabolic syndrome. Korean J Urol 2006;47:257-62
14. Sohn JC, Chang HS, Kim CI. The correlation between metabolic syndrome and the prostate volume. Korean J Urol 2007;48:603-7
15. Ku JH, Ahn JO, Lee CH, Lee NK, Park YH, Byun SS, et al. Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity. Urology 2002;60:475-9
16. Kwon NS, Jo MK, Park K. The relationship between the metabolic syndrome and the risk of benign prostatic hyperplasia: a hospital-based study from a health screening population. Korean J Urol 2007;48:1016-21
17. Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, et al. Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. Endocrinology 1994;134:1039-45
18. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 1997;13:65
19. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-9
20. Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005;28:1810-2
21. Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986;61:1081-90
22. Glasser DB, Carson C 3rd, Kang JH, Laumann EO. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study. Int J Clin Pract 2007;61:1294-300
23. Dahle SE, Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002;168:599-604
24. Burke JP, Rhodes T, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol 2006;164:41-6
25. Zucchetto A, Tavani A, Dal Maso L, Gallus S, Negri E, Talamini R, et al. History of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obes (Lond) 2005;29:798-803
26. Michel MC, Heemann U, Schumacher H, Mehlburger L, Goepel M. Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol 2004;172:1390-3